Prior to April 22, 2026, the FDA placed these peptides as Category 2 Bulk drug substances, which have since been nominated for the 503A compounding list
For individuals whose insurance doesn't cover GLP-1 medications or whose plans impose significant barriers to access, the direct-to-consumer model may provide faster, more reliable access
Treatment of Endometriosis and Leiomyoma with the Association of Miodesin and Gestrinone in Pentravan Through the Vaginal Route
Furthermore, health risks, family history, other medications, age, and personal health factors, are also going to dictate the results you are going to see, and how quickly you can expect to see those results
Each vial is carefully manufactured and sealed to ensure product stability and sterility during storage and laboratory handling